about
Risk factors for osteoporosis in female patients with systemic lupus erythematosus.Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease.No deleterious effect of low dose methotrexate on titanium implant osseointegration in a rabbit model.Use of methotrexate in the management of sight-threatening uveitis.Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.Insufficiency fractures: A rare cause of foot and ankle pain in three patients with rheumatoid arthritis.
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Methotrexate osteopathy in rheumatic disease.
@ast
Methotrexate osteopathy in rheumatic disease.
@en
Methotrexate osteopathy in rheumatic disease.
@nl
type
label
Methotrexate osteopathy in rheumatic disease.
@ast
Methotrexate osteopathy in rheumatic disease.
@en
Methotrexate osteopathy in rheumatic disease.
@nl
prefLabel
Methotrexate osteopathy in rheumatic disease.
@ast
Methotrexate osteopathy in rheumatic disease.
@en
Methotrexate osteopathy in rheumatic disease.
@nl
P2093
P2860
P356
P1476
Methotrexate osteopathy in rheumatic disease.
@en
P2093
P2860
P304
P356
10.1136/ARD.52.8.582
P407
P577
1993-08-01T00:00:00Z